Spots Global Cancer Trial Database for aldara
Every month we try and update this database with for aldara cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC) | NCT00581425 | Basal Cell Carc... | Imiquimod and I... | - | The University of Texas Health Science Center, Houston | |
A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients | NCT00189267 | Actinic Keratos... | Imiquimod 5 % C... | 18 Years - | Viatris Inc. | |
Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions | NCT00294320 | Actinic Keratos... | Aldara (Imiquim... Vehicle cream | 18 Years - | Viatris Inc. | |
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC) | NCT00581425 | Basal Cell Carc... | Imiquimod and I... | - | The University of Texas Health Science Center, Houston | |
Comparing Immune Responses to Topical Imiquimod | NCT04809662 | Actinic Keratos... | Imiquimod | 18 Years - 85 Years | University of California, Davis | |
Efficacy and Tolerability of Topical LFX453 for External Genital Warts | NCT02482428 | External Genita... | Investigational... Aldara | 18 Years - 60 Years | Novartis | |
A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients | NCT00189267 | Actinic Keratos... | Imiquimod 5 % C... | 18 Years - | Viatris Inc. | |
Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma | NCT01264731 | Melanoma | MELITAC 12.1 Imiquimod | 18 Years - | University of Virginia | |
Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts | NCT00189293 | Genital Warts | Imiquimod vehicle cream | 18 Years - | Viatris Inc. | |
Comparing Immune Responses to Topical Imiquimod | NCT04809662 | Actinic Keratos... | Imiquimod | 18 Years - 85 Years | University of California, Davis | |
A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma | NCT00189241 | Basal Cell Carc... | imiquimod | 18 Years - | Viatris Inc. | |
1-Year Follow up to the 1473-IMIQ Study | NCT00114023 | Keratosis | Imiquimod 5% cr... | 18 Years - | Graceway Pharmaceuticals, LLC | |
Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream | NCT00189306 | Superficial Bas... | Imiquimod 5% cr... | 18 Years - | Graceway Pharmaceuticals, LLC | |
Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts | NCT00189293 | Genital Warts | Imiquimod vehicle cream | 18 Years - | Viatris Inc. | |
Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream | NCT00189306 | Superficial Bas... | Imiquimod 5% cr... | 18 Years - | Graceway Pharmaceuticals, LLC |